PennyTrader.com Presents Today’s Midday Stock Report: EMPO, BSDM, ONCS, DKGR
After a failed rally to breakeven, the key indices have slipped back near their session lows. The S&P 500 is off by 0.2%.
Stanley Black & Decker (SWK 74.39, +0.16) has entered into a definitive agreement to sell its Hardware & Home Improvement Group to Spectrum Brands (SPB 46.10, +4.94) for $1.4 billion in cash. With 90% of HHI’s revenue from North America and more than 50% of its revenue coming through U.S. home centers, the divestiture of HHI is a meaningful step in the continued diversification of Stanley Black & Decker’s revenue streams and geographic footprint. As a result, SWK is showing little change while SPB is higher by 12.0%.
EMPO – Volume Alert
Volume for last two days has been significantly above it’s average volume.
Empowered Products, in just its first 10 years of operation, has quickly forged a leading presence in the global wellness industry with the development, manufacture, and distribution of currently 17 high quality, elegantly packaged wellness products. Headquartered in Nevada, USA, the Company’s empowering products are currently available at over 3,000 retail locations in more than 30 countries spanning four continents. Empowered Products (OTC-QB: EMPO) announced last week their PINK® and Gun-Oil® lines of sensual lubricants and libido-enhancing supplements launched into the mainstream retail sector – most recently with Walgreens and CVS.
To Read Full Story go to: http://www.pennytrader.com/
********************
BSDM – Trade Alert
Up 67.80% in morning trading to $1.98 with 1M shares traded
BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. The Company has developed extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. BSD Medical Corporation (NASDAQ:BSDM) announced today a 391% increase in sales for the MicroThermX® Microwave Ablation System (MicroThermX®) product line for September 2012, as compared to September 2011.
To Read Full Story go to: http://www.pennytrader.com/
********************
ONCS – News Alert
Up 15% in morning trading to $.299 with 850K shares traded
OncoSec Medical Incorporated is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives. OncoSec’s core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec’s clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. OncoSec Medical Inc. (OTCBB: ONCS) announced the company will be presenting data at two upcoming medical conferences.
To Read Full Story go to: http://www.pennytrader.com/
********************
DKGR – News Alert
Up 28.57% in morning trading to $.0009 with 30M shares traded
Drake Gold Resources, Inc. is a property development holding company focused on developing projects through acquisitions that focus on income producing oil & gas properties. The Company has completed the first acquisition of private, producing, oil & gas assets. Drake Gold Resources Inc. (OTC:DKGR) announces today that its joint venture with Parker Technologies has finalized a 40 acre working interest for shallow rights on up to 750 acres of resource rich land in Southwest Texas.
To Read Full Story go to: http://www.pennytrader.com/
To Follow PennyTrader on Twitter: http://twitter.com/pennytrader
To Join Our Facebook Page: http://www.facebook.com/PennyTrader2
PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Disclosure: PennyTrader.com and affiliates have been compensated Four Thousand Five Hundred dollars
by a unaffiliated third party (Crown Pacifica) for promotional coverage of EMPO.
Leave a Comment